Ye, S., Zhao, X., Hu, X., Li, T., Xu, Q., Yang, H., . . . Yang, L. (2017). TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma. Oncol Rep.
Citação norma ChicagoYe, Song, Xin-Yi Zhao, Xiao-Ge Hu, Tang Li, Qiu-Ran Xu, Huan-Ming Yang, Dong-Sheng Huang, and Liu Yang. "TP53 and RET May Serve As Biomarkers of Prognostic Evaluation and Targeted Therapy in Hepatocellular Carcinoma." Oncol Rep 2017.
MLA citiranjeYe, Song, et al. "TP53 and RET May Serve As Biomarkers of Prognostic Evaluation and Targeted Therapy in Hepatocellular Carcinoma." Oncol Rep 2017.
Opozorilo: Ti citati niso vedno 100% točni.